| Sativex (nabiximols) / Jazz |
2022-001777-31: Pilot study on the effect of cannabinoids THC + CBD on resistant spasticity in patients with chronic spinal cord injury. Estudio piloto sobre el efecto de los cannabinoides THC+CBD en la espasticidad resistente en pacientes con lesión medular crónica |
|
|
| Not yet recruiting | 4 | 20 | Europe | Sativex 2,7 mg / 2,5 mg Solución para pulverización bucal, Oral spray, suspension, Sativex 2,7 mg / 2,5 mg Solución para pulverización bucal | Hospital de Neurorrehabilitación Institut Guttmann, Almirall S.A. | Pilot study on the effect of THC+CBD cannabinoids on resistant spasticity in patients with chronic spinal cord injury. Estudio piloto sobre el efecto de los cannabinoides THC+CBD en la espasticidad resistente en pacientes con lesión medular crónica., Pilot study on the effect of THC+CBD cannabinoids on resistant spasticity in patients with chronic spinal cord injury. Estudio piloto sobre el efecto de los cannabinoides THC+CBD en la espasticidad resistente en pacientes con lesión medular crónica., Diseases [C] - Nervous System Diseases [C10] | | | | |
2020-003271-18: A trial to test how efficient Nabiximols is for treatment of spacticity in patients with Multiple Sclerosis |
|
|
| Ongoing | 3 | 190 | RoW, Europe | Nabiximols - Sativex, Oromucosal spray, solution, Sativex Oromucosal Spray | GW Pharma Limited, GW Pharma Limited | Symptomatic treatment of spasticity in patients with multiple sclerosis (MS), Treatment of muscle spasm in patients with multiple sclerosis (MS), Diseases [C] - Nervous System Diseases [C10] | | | | |
2020-004306-58: A study to asses the effects of Nabiximols on spasticity associated with multiple sclerosis. |
|
|
| Not yet recruiting | 3 | 575 | Europe | Nabiximols - Sativex, Oromucosal spray, solution | GW Pharma Limited, GW Pharma Ltd | Symptomatic treatment of spasticity in patients with MS, Multiple Sclerosis (MS), Diseases [C] - Nervous System Diseases [C10] | | | | |
| Terminated | 3 | 139 | Europe, US, RoW | Nabiximols, GW-1000-02, Sativex, Placebo | Jazz Pharmaceuticals | Multiple Sclerosis (MS) | 02/23 | 02/23 | | |
2018-004378-92: Study of the effect of cannabis in relieving the symptoms of endometriosis Estudio del efecto del canabis en el alivio de los síntomas de la endometriosis |
|
|
| Not yet recruiting | 2 | 10 | Europe | Sativex, Oromucosal spray, Sativex | Fundació Clínic per la Recerca Biomèdica, Almirall | Deep endometriosis Endometriosis profunda, Endometriosis Endometriosis, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2020-001056-17: A randomised feasibility trial investigating Sativex® for the treatment of the Agitation & Aggression (A/A) in Alzheimer’s Dementia |
|
|
| Not yet recruiting | 2 | 60 | Europe | Sativex Oromucosal Spray, Oromucosal spray, Sativex Oromucosal Spray | Kings's College London, South London and Maudsley NHS Foundation Trust, Alzheimer's Research UK | Clinically significant agitation in Alzheimer's Diseases, Clinically significant agitation in Alzheimer's Diseases, Psychiatry and Psychology [F] - Behaviours [F01] | | | | |
| Recruiting | 2 | 234 | Europe | Nabiximols, Sativex, Temozolomide, Nabiximols-matched placebo | University of Birmingham, University of Leeds, The Brain Tumour Charity, Jazz Pharmaceuticals | Glioblastoma, Brain Tumor, Cannabis, Brain Tumor, Recurrent | 02/26 | 02/27 | | |
SENS-NMO, NCT05974293: A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders |
|
|
| Not yet recruiting | 2 | 44 | US | Nabiximols, Sativex, Placebo | Michael, Levy M.D.,Ph.D., Jazz Pharmaceuticals | NMO Spectrum Disorder, Spasticity, Muscle | 04/26 | 09/26 | | |
2019-002786-35: Excretion and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis. Udskillelse og bivirkninger for tetrahydrocannabinol og cannabidiol (Sativex) hos patienter med nyreinsufficiens og patienter i dialyse. |
|
|
| Ongoing | 1/2 | 85 | Europe | Oromucosal spray, Sativex | Charlotte Uggerhøj Andersen, Aarhus University Hospital, Aarhus University, The Danish Regions, The Health Research Foundation of Central Denmark Region, Helsefonden, A.P. Møller Fonden, Nyreforeningen | Chronic kidney disease Kronisk nyreinsufficiens, Kidney disease Nyresygdom, Body processes [G] - Physiological processes [G07] | | | | |